{"schema_version":"secwatch.filing_event.v1","accession":"0001522767-23-000100","form_type":"8-K","ticker":"MRMD","cik":"0001522767","company_name":"MARIMED INC.","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.185216+00:00","generated_at":"2026-06-12T13:08:07.734398+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MariMed Q2 revenue $36.5M (+11% YoY); GAAP net loss $0.9M vs $1.9M profit","bullets":["Revenue $36.5M, up 11% from $33.0M year-over-year; wholesale set monthly and quarterly records.","GAAP net loss $0.9M vs income $1.9M in Q2 2022; non-GAAP net income $0.6M vs $5.5M.","Adjusted EBITDA $6.3M (17% margin) down from $8.9M (27% margin) last year; 14th straight positive quarter.","Non-GAAP gross margin 46% flat YoY; balance sheet remains one of strongest in industry.","Adult-use sales in Maryland commenced July 1, 2023, driving expected acceleration."],"urls":{"canonical":"https://secwatch.observer/filing/0001522767-23-000100","json":"https://secwatch.observer/filing/0001522767-23-000100.json","markdown":"https://secwatch.observer/filing/0001522767-23-000100.md","text":"https://secwatch.observer/filing/0001522767-23-000100.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522767/000152276723000100/0001522767-23-000100-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522767/000152276723000100/mrmd-20230802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T13:08:07.734398+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}